Invention Grant
- Patent Title: Quinoline derivative
- Patent Title (中): 喹啉衍生物
-
Application No.: US13138300Application Date: 2010-01-29
-
Publication No.: US08383647B2Publication Date: 2013-02-26
- Inventor: Toshiki Murata , Masahiro Kamaura
- Applicant: Toshiki Murata , Masahiro Kamaura
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Foley & Lardner LLP
- Priority: JP2009-020575 20090130
- International Application: PCT/JP2010/051277 WO 20100129
- International Announcement: WO2010/087454 WO 20100805
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; A61P3/04 ; C07D215/38
Abstract:
The present invention provides a compound having a melanin-concentrating hormone receptor antagonistic action and low toxicity, which is useful as an agent for the prophylaxis or treatment of obesity and the like.The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.
Public/Granted literature
- US20120035213A1 Quinoline derivative Public/Granted day:2012-02-09
Information query
IPC分类:
